Wells Fargo Maintains Equal-Weight on ShockWave Medical, Lowers Price Target to $251
Portfolio Pulse from jenniferd'souza@benzinga.com
Wells Fargo analyst Larry Biegelsen has maintained an Equal-Weight rating on ShockWave Medical (NASDAQ:SWAV) and lowered the price target from $275 to $251.
August 08, 2023 | 1:53 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Wells Fargo has maintained an Equal-Weight rating on ShockWave Medical and lowered the price target from $275 to $251.
The news is directly related to ShockWave Medical as Wells Fargo has maintained an Equal-Weight rating on the company and lowered the price target. This could potentially impact investor sentiment and the stock's price, but the direction of the impact is uncertain as the rating is maintained while the price target is lowered.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100